Professor Matthew Collin is an Honorary Consultant Haematologist and Professor of Haematology at the Northern Centre for Cancer Care specialising in Bone Marrow Transplantation, Histiocytosis and Adult Immunodeficiency.
Professor Collin attained a PhD in Immunology 1992 and Medical Degree 1995 at Oxford University before carrying out specialist training in Haematology and Transplantation 2004 in the Northern Region). He has been a Consultant Haematologist since 2006, and Professor of Haematology and Director of Bone Marrow Transplantation since 2010.
His clinical expertise is in bone marrow transplantation, aiming to provide a top quality modern and innovative service to patients from across the region.
Research expertise is in human dendritic cell (DC) biology including discovery and classification of human DCs, role of DCs in graft versus host disease, genetic DC deficiency due to GATA2 mutation and IRF8 mutation (both discovered in Newcastle) and the histiocytic disorders Langerhans Cell Histiocytosis and Erdheim Chester Disease.
Major research funding from Bloodwise (formerly Leukaemia Research Fund) CRUK, Wellcome Trust and MRC. More details of research at http://www.hudendritic.org.
Professor Collin is a Founding Trustee of local blood cancer charity Bright Red.
